Scientists have found a way to make heart cells divide again. But so far, only in mice.
Get the latest international news and world events from around the world.
Blocking excess scarring helps prevent heart failure development
Most heart failure cases are caused to a large degree by a buildup of excess scar tissue in the heart, which currently has no treatments. Now, researchers have successfully prevented the development of severe heart failure in a mouse model of heart attack by blocking a protein that triggers the formation of excessive scar tissue.
Reducing the level of this protein, called AEBP1, after a heart attack or prolonged hypertension could be a promising therapy to prevent heart failure development.
“For the first time, we show that if we suppress AEBP1, it prevents heart failure progression and preserves cardiac function,” says Thirupura Shankar, Ph.D., a postdoctoral researcher in the Nora Eccles Harrison Cardiovascular Research Training Institute at University of Utah Health and first author on the study.
Stigmatizing patient details can push AI to deprioritize high-risk emergency cases
Artificial intelligence (AI)-driven tools used in emergency triage may be susceptible to the same clinical stigmas associated with human assessments, researchers at UT Southwestern Medical Center reported in a study published in npj Digital Medicine. Their findings suggest this could result in harmful biases and wrongful prioritization of patients.
“Wording matters. Because AI models process the words we use to describe patients, stigmatizing language can steer clinicians away from the patients who need care the most,” said first author Philip Jarrett, M.D., MBA, assistant professor of emergency medicine. “This study is part of a broader research program on how clinical information should be presented to AI so it can safely help prioritize emergency patients competing for limited resources.”
The team analyzed patient records from emergency departments (EDs) at two major academic institutions: Stanford Medicine in California and Beth Israel Deaconess Medical Center in Massachusetts. They paired patients with similar initial condition severity levels, then asked three open-source AI large language models (LLMs) to predict which patients were more likely to deteriorate and who should be prioritized for care. Before demographic, social or potentially stigmatizing information was added, all three models identified higher-risk patients at rates well above chance.
Tirzepatide moves more than half of treated teens below obesity threshold, new clinical trial reports
Tirzepatide (Zepbound) is a once-weekly injectable medication that hits two targets at once. This dual-action drug mimics the effects of two natural gut hormones in the body—glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). Working together, these hormones keep blood sugar in check, slow the movement of food through the gut and signal the brain about fullness, which helps manage appetite and food intake.
A Phase III clinical trial called SURMOUNT-ADOLESCENTS tested whether a once-weekly dose of tirzepatide combined with healthy lifestyle counseling is safe and effective for helping teenagers lose weight and improve their health.
A total of 160 teenagers across 31 medical centers in six countries who had obesity or were overweight with at least one related health complication such as high blood pressure or prediabetes received either a once-weekly shot of tirzepatide or a placebo for 72 weeks.
Key immune driver of pancreatic cancer points to combination treatment for slowing progression
Researchers from The University of Texas MD Anderson Cancer Center have discovered that the IL-18 inflammatory protein helps pancreatic tumors grow and evade the immune system, highlighting its potential as a therapeutic target for pancreatic cancer.
Reducing levels of IL-18 in preclinical models reshaped the tumor microenvironment, slowed tumor growth, improved survival and enhanced the effects of KRAS-targeted therapies.
The study, published in Gastroenterology, was co-led by Yang Chen, Ph.D., assistant professor of Translational Molecular Pathology, and Xinlei Sun, Ph.D., postdoctoral fellow in Translational Molecular Pathology.
Human skin models reveal how herpes spreads unevenly among neighboring cells
Researchers at the Max Delbrück Center and University Medical Center Hamburg-Eppendorf have traced how herpes simplex virus 1 infection progresses among neighboring skin cells in skin organoids. The work is published in Science Advances.
Most people think of herpes simplex virus 1 (HSV-1) as a mere cosmetic problem: The virus can cause outbreaks of cold sores on the lips or face, which usually heal on their own within two weeks. But HSV-1 infection can be more sinister. The virus infects sensory nerve cells in the face, where it usually remains dormant.
In rare cases, it travels to the central nervous system and causes life-threatening brain inflammation. HSV-1 is also being investigated for potentially playing a role in Alzheimer’s disease—its lifelong persistence in our nervous system may eventually damage nerve cells.
Precision RNA therapy offers hope for brain receptor disorders
Scientists at Johns Hopkins University School of Medicine and Academia Sinica in Taiwan have developed an experimental RNA-based treatment that prevents brain damage and improves learning, memory and social behavior in mice carrying a rare genetic mutation associated with autism spectrum disorder and intellectual disability.
The research is published in the journal Neuron.
Through this research, the investigators showed how a mutation in GRIA1, a gene encoding a key component of AMPA receptors, disrupts brain development. These receptors control communication between neurons and are essential for learning and memory.
Cell reprogramming could make tumors more responsive to immunotherapy
In a new international study led by Lund University in Sweden, researchers have uncovered how reprogrammed cancer cells can help orchestrate the immune system’s attack on tumors. Experiments in mice revealed how immune cells are recruited and organized within tumors to mount an immune response. The findings could pave the way for more effective immunotherapy and, ultimately, help more patients benefit from the treatment.
Immunotherapy is a treatment that helps the body’s own immune system fight cancer. The treatment has fundamentally changed cancer care, but it still does not work for everyone—particularly with cancers that are difficult to treat.
Our increasingly cluttered skies
As Earth’s orbital space becomes ever more crowded, collisions and debris threaten not only commercial assets and astronauts’ lives, but also safety and property on the ground.
How Small Errors Changed The Future Of Space Exploration
Behind every monumental leap in space exploration lies a hidden history of narrow escapes and devastating failures. From a technician’s wrong turn with a joystick to a $100 million deep-space probe plummeting into the Utah desert because of a single sensor installed backward, this documentary explores how human \.








